Your browser doesn't support javascript.
loading
Targeting carbonic anhydrase IX improves the anti-cancer efficacy of mTOR inhibitors.
Faes, Seraina; Planche, Anne; Uldry, Emilie; Santoro, Tania; Pythoud, Catherine; Stehle, Jean-Christophe; Horlbeck, Janine; Letovanec, Igor; Riggi, Nicolo; Datta, Dipak; Demartines, Nicolas; Dormond, Olivier.
Afiliación
  • Faes S; Department of Visceral Surgery, University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Planche A; Department of Visceral Surgery, University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Uldry E; Department of Visceral Surgery, University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Santoro T; Department of Visceral Surgery, University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Pythoud C; Department of Visceral Surgery, University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Stehle JC; Mouse Pathology Facility, University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Horlbeck J; Mouse Pathology Facility, University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Letovanec I; Institute of Pathology, University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Riggi N; Institute of Pathology, University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Datta D; Biochemistry Division, CSIR-Central Drug Research Institute, Lucknow, India.
  • Demartines N; Academy of Scientific and Innovative Research, New Delhi, India.
  • Dormond O; Department of Visceral Surgery, University Hospital and University of Lausanne, Lausanne, Switzerland.
Oncotarget ; 7(24): 36666-36680, 2016 Jun 14.
Article en En | MEDLINE | ID: mdl-27153561

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Sirolimus / Serina-Treonina Quinasas TOR / Anhidrasa Carbónica IX / Acetazolamida Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Sirolimus / Serina-Treonina Quinasas TOR / Anhidrasa Carbónica IX / Acetazolamida Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article